Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

About Noven


Our Mission

To develop and offer pharmaceutical products that meaningfully benefit patients around the world, with a commitment to advancing patient care through transdermal drug delivery.

Our Values


Our Leadership Principles


 

Fast Facts

Core Business:

Specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products.

Year of Incorporation:

1987

Employees:

Over 325

Chief Executive Officer:

Jeff Mihm

Media, General Business
& Other Inquiries:

Tel: 305-253-1916
CorporateAffairs@noven.com

Partnering and Other Business Development Opportunities

Tel: 551-233-2700
BusDev@noven.com

Physican Payment
Sunshine Act Inquiries:

Aggspend@noven.com

Employment Inquiries:

Rory Kelly
Associate Director – Recruiting
rkelly@noven.com
Careers Page

Community Support:

Corporate Social Responsibility

Affiliated Companies:

Noven is a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc. – bringing the benefits of patch therapy to patients around the world.

Noven's commercialized products are marketed and sold through Noven Therapeutics, LLC.

Grove Pharmaceuticals is the generic division of Noven Therapeutics, LLC.